Can you name specific bacterial infections for tigecycline?

Which bacterial infections does tigecycline cover?

Tigecycline is used for serious bacterial infections caused by susceptible organisms. Common infection types include complicated skin and skin structure infections (cSSSI) and complicated intra-abdominal infections (cIAI) [1].

What specific infection types are usually named in tigecycline use?

In practice, tigecycline is associated with the following specific clinical infection categories:
- Complicated skin and skin structure infections (cSSSI) [1]
- Complicated intra-abdominal infections (cIAI) [1]

Are there particular “infection names” tied to common bacteria?

Tigecycline’s use is generally framed by the infection syndrome (like cSSSI or cIAI) rather than single named diseases. The specific bacterial targets depend on the susceptibility testing results and local labeling guidance for the indication being treated [1].

What to check if you need the exact bacteria–infection pairing?

For the most precise mapping between tigecycline and specific bacteria in each infection type, you would need the product’s labeled indication details and activity/susceptibility tables for the relevant country/label. If you share the country (US/EU/etc.) or a specific label reference, I can help narrow it down.

Sources:
[1] https://www.drugs.com/tigecycline.html